THX Pharma Société Anonyme Logo

THX Pharma Société Anonyme (ALTHX)

Euronext

Currency in EUR
3.25
-0.02 (-0.61%)

Closed

Oct 7, 2026

Day's Range

3.25
3.33

52 wk Range

1.49
5.10

Overview - ALTHX - THX Pharma Société Anonyme

Key Statistics

Valuation

Enterprise Value

38.71M

P/E (Forward)

‪-1.71‬

PEG Ratio

‪-1.71‬

Price / Sales (TTM)

‪56.80‬

Price / Book

‪15.04‬

EV / EBITDA

‪-9.82‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-144,876,610.00%‬

Return on Assets

‪-35.42%‬

Return on Equity

‪-482.39%‬

Ownership

Shares Outstanding

13.76M

Float

13.13M

Held by Insiders

‪12.84%‬

Held by Institutions

‪19.71%‬

Price stats

Beta

‪1.51‬

50-Day Avg

‪3.91‬

200-Day Avg

‪3.30‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

1 analysts

News Teaser - ALTHX - THX Pharma Société Anonyme

News & Analysis

View all news

Market Cap - ALTHX - THX Pharma Société Anonyme

Peers - ALTHX - THX Pharma Société Anonyme

Peer Comparison

Compared with companies in Biotechnology listed on Euronext.

Profile Summary - ALTHX - THX Pharma Société Anonyme

About

THX Pharma Société Anonyme is a French biopharmaceutical company focused on developing treatments for rare neurological diseases and central nervous system disorders. The company works on drug candidates designed to address conditions with limited therapeutic options, with a particular emphasis on innovative…

SectorHealthcare
IndustryBiotechnology
Employees12
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.